Related Experiment Video
Updated: May 29, 2026

10:51
Microfluidic Fabrication of Core-Shell Microcapsules carrying Human Pluripotent Stem Cell Spheroids
Published on: October 13, 2021
Facile spray-drying assembly of uniform microencapsulates with tunable core-shell structures and controlled release
Wenjie Liu1, Winston Duo Wu, Cordelia Selomulya
1Department of Chemical Engineering, Monash University, Clayton, Victoria 3800, Australia.
Langmuir : the ACS Journal of Surfaces and Colloids
|September 24, 2011
Summary
Researchers developed a scalable method for creating core-shell microencapsulates using Eudragit RS and silica. This technique enables controlled release applications by precisely tuning particle architecture without organic solvents.
Area of Science:
- Materials Science
- Chemical Engineering
- Drug Delivery
Background:
- Core-shell microencapsulates offer tunable functionalities for controlled release and encapsulation.
- Existing methods for producing these particles can be complex and may involve organic solvents.
Purpose of the Study:
- To develop an efficient, scalable, and solvent-free method for producing uniform core-shell microencapsulates.
- To investigate the controlled release properties of these microencapsulates based on their architecture.
Main Methods:
- Utilized a single-step spray-drying assembly with Eudragit RS as the shell and silica as the core.
- Employed evaporation-induced self-assembly for phase separation and core-shell formation.
- Used a microfluidic jet spray dryer for precise control over particle uniformity and shell thickness.
Main Results:
- Successfully formed uniform silica-core/Eudragit RS-shell microparticles without organic solvents.
- Demonstrated direct control over shell thickness by adjusting precursor ingredient ratios.
- Investigated controlled release of rhodamine B, showing significant dependence on microencapsulate architecture.
Conclusions:
- The developed spray-drying method provides an efficient and scalable route to core-shell microencapsulates.
- The particle architecture significantly influences controlled release behavior, offering potential for tailored drug delivery systems.

